These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19453536)

  • 1. Prognostic significance of several histological features in intermediate and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Rejeki V; Herschtal A; Bernshaw D; Quinn M; Jobling T; Allen D
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):107-13. PubMed ID: 19453536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.
    Briët JM; Hollema H; Reesink N; Aalders JG; Mourits MJ; ten Hoor KA; Pras E; Boezen HM; van der Zee AG; Nijman HW
    Gynecol Oncol; 2005 Mar; 96(3):799-804. PubMed ID: 15721428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
    Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
    Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial adenocarcinoma: an analysis of treatment and outcome.
    Byrd LM; Swindell R; Webber-Rookes D; Hannon R; Hunter RD; Livsey J; Davidson SE
    Oncol Rep; 2008 Nov; 20(5):1221-8. PubMed ID: 18949425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
    Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of vascular invasion by endometrial carcinoma.
    Inoue Y; Obata K; Abe K; Ohmura G; Doh K; Yoshioka T; Hoshiai H; Noda K
    Cancer; 1996 Oct; 78(7):1447-51. PubMed ID: 8839550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
    Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The grading of lymphovascular space invasion in endometrial carcinoma.
    Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M
    Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complete para-aortic lymphadenectomy in endometrial cancer.
    Fujimoto T; Fukuda J; Tanaka T
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):10-4. PubMed ID: 19124998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues surrounding lymphadenectomy in the management of endometrial cancer.
    Bernardini MQ; Murphy JK
    J Surg Oncol; 2009 Mar; 99(4):232-41. PubMed ID: 19072933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.